Balyasny Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Sell |
1,311,480
-203,605
| -13% | -$1.91M | 0.02% | 641 |
|
|
2025
Q1 | $10.8M | Sell |
1,515,085
-791,209
| -34% | -$5.63M | 0.02% | 627 |
|
|
2024
Q4 | $26.9M | Buy |
2,306,294
+1,556,433
| +208% | +$18.1M | 0.04% | 410 |
|
|
2024
Q3 | $15.4M | Buy |
749,861
+402,378
| +116% | +$8.27M | 0.03% | 533 |
|
|
2024
Q2 | $7.78M | Buy |
347,483
+158,982
| +84% | +$3.56M | 0.01% | 708 |
|
|
2024
Q1 | $5.19M | Buy |
+188,501
| New | +$5.19M | 0.01% | 851 |
|
|
2023
Q1 | – | Sell |
-762
| Closed | -$26.6K | – | 2499 |
|
|
2022
Q4 | $26.6K | Sell |
762
-38,927
| -98% | -$1.36M | ﹤0.01% | 2007 |
|
|
2022
Q3 | $2.22M | Buy |
+39,689
| New | +$2.22M | 0.01% | 1090 |
|
|
2021
Q2 | – | Sell |
-38,720
| Closed | -$3.11M | – | 1940 |
|
|
2021
Q1 | $3.11M | Sell |
38,720
-44,473
| -53% | -$3.57M | 0.02% | 726 |
|
|
2020
Q4 | $4.53M | Buy |
+83,193
| New | +$4.53M | 0.03% | 578 |
|
|
2019
Q3 | – | Sell |
-57,321
| Closed | -$938K | – | 1297 |
|
|
2019
Q2 | $938K | Buy |
57,321
+11,675
| +26% | +$191K | 0.01% | 958 |
|
|
2019
Q1 | $780K | Sell |
45,646
-1,265
| -3% | -$21.6K | 0.01% | 984 |
|
|
2018
Q4 | $640K | Buy |
+46,911
| New | +$640K | ﹤0.01% | 934 |
|